Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end flat as defensive gains offset auto slide

Mon, 18th Nov 2019 17:51

* Spanish bourse BME hits 4-year high

* Volkswagen cuts sales and profit forecast

* Defensive shares gain amid trade uncertainty

* FTSE 100 outperforms
(Updates to close, changes quotes, adds news items)

By Medha Singh and Agamoni Ghosh

Nov 18 (Reuters) - European stocks ended flat on Monday as a
spurt of defensive buying over uncertainty surrounding
U.S.-China trade talks helped temper losses in the auto sector.

The pan-European STOXX 600 index finished little
changed, after having spent most of the session in negative
territory.

The European automobiles and parts sector dropped
2.1%, its steepest fall in about four weeks, with Germany's
Volkswagen leading declines after it slashed its
operating profit and sales growth outlook due to slowdown in the
auto sector.

"Volkswagen is seen as a barometer for the industry and any
kind of warning from them can be concerning," said David Madden,
market analyst at CMC Markets in London.

This comes after a string of automakers including fellow
German peer Daimler and part supplier Continental
warned of tough times for an industry facing higher
investments into cleaner and self-driving technologies.

Also weighing on the sector was an over 3% decline in shares
of France's Peugeot after Deutsche Bank downgraded the
stock to "hold."

Conflicting trade headlines kept investors cautious with
sectors traditionally considered defensive, such as real estate
, utilities and healthcare leading
gains.

News on the trade war was conflicting. Sentiment in the
afternoon took a hit after a CNBC report said the mood in
Beijing about a deal was pessimistic due to U.S. President
Donald Trump's reluctance to roll back tariffs.

However, late in the session, the Trump administration
issued a new 90-day extension allowing U.S. companies to
continue doing business with China's Huawei Technologies Co Ltd
.

"The comments from both countries are getting hard to follow
now, they change their tone every other day," said Hubert de
Barochez, economist at Capital Economics, London.

Gains in defensive stocks including AstraZeneca,
GlaxoSmithKline and British American Tobacco
helped London's blue-chip FTSE 100 rise 0.1%, to
outperform the broader market.

Optimism surrounding a Sino-U.S. trade talks and better than
expected corporate results had helped STOXX 600 hit 4 year high
last week.

In a bright spot, shares of Bolsas y Mercados Espanoles
(BME) rocketed 38% as stock market operator Euronext
and Switzerland's SIX sparked a bidding war for the
Spanish firm, with both trying to snap up one of Europe's last
standalone stock exchanges.

Qiagen jumped 8% after the German genetic testing
company said it would start talks with several potential
suitors.
(Reporting by Medha Singh and Agamoni Ghosh in Bengaluru;
Editing by Shounak Dasgupta, Patrick Graham and Toby Chopra)

More News
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.